Online first
Original article
Published online: 2024-06-28
A new perspective on aortic pressure for transcatheter closure of patent ductus arteriosus in the pediatric population
Abstract
Not available
References
- Jin M, Liang YM, Wang XF, et al. A Retrospective Study of 1,526 Cases of Transcatheter Occlusion of Patent Ductus Arteriosus. Chin Med J (Engl). 2015; 128(17): 2284–2289.
- Wierny L, Plass R, Porstmann W. Transluminal closure of patent ductus arteriosus: long-term results of 208 cases treated without thoracotomy. Cardiovasc Intervent Radiol. 1986; 9(5-6): 279–285.
- Porstmann W, Hieronymi K, Wierny L, et al. Nonsurgical closure of oversized patent ductus arteriosus with pulmonary hypertension. Report of a case. Circulation. 1974; 50(2): 376–381.
- Rashkind WJ, Mullins CE, Hellenbrand WE, et al. Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System. Circulation. 1987; 75(3): 583–592.
- Rao PS, Sideris EB, Haddad J, et al. Transcatheter occlusion of patent ductus arteriosus with adjustable buttoned device. Initial clinical experience. Circulation. 1993; 88(3): 1119–1126.
- Saliba Z, El-Rassi I, Abi-Warde MT, et al. The Amplatzer Duct Occluder II: a new device for percutaneous ductus arteriosus closure. J Interv Cardiol. 2009; 22(6): 496–502.
- Gałeczka M, Szkutnik M, Białkowski J, et al. Transcatheter patent ductus arteriosus closure: what have we learned after over 25 years? A single--center experience with 1036 patients. Kardiol Pol. 2021; 79(3): 287–293.
- Feng J, Kong X, Sheng Y, et al. Patent ductus arteriosus with persistent pulmonary artery hypertension after transcatheter closure. Ther Clin Risk Manag. 2016; 12: 1609–1613.
- Baruteau AE, Hascoët S, Baruteau J, et al. Transcatheter closure of patent ductus arteriosus: past, present and future. Arch Cardiovasc Dis. 2014; 107(2): 122–132.
- Lee JA. Practice for preterm patent ductus arteriosus; focusing on the hemodynamic significance and the impact on the neonatal outcomes. Korean J Pediatr. 2019; 62(7): 245–251.
- Kaczmarek D, Matuszewska-Brycht O, Piestrzeniewicz K, et al. Patent ductus arteriosus: Generally an anomaly of childhood, but is it always? Clinical implications in an adult patient. Kardiol Pol. 2023; 81(10): 1030–1031.
- Rangaswami J, Bhalla V, Blair JEA, et al. American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation. 2019; 139(16): e840–e878.
- Stompór T, Winiarska A. Kidneys in heart failure: Impact of flozins. Kardiol Pol. 2023; 81(11): 1071–1080.
- Capozzi G, Santoro G. Patent ductus arteriosus: patho-physiology, hemodynamic effects and clinical complications. J Matern Fetal Neonatal Med. 2011; 24 Suppl 1: 15–16.
- Talner NS. The physiology of congenital heart disease.Garson A, Bricker TJ, Fisher DJ, Neish SR. ed. The Science and Practice of Pediatric Cardiology, 2nd, Baltimore 1998.
- Krichenko A, Benson LN, Burrows P, et al. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol. 1989; 63(12): 877–880.
- Nichols W, O’Rourke M, Vlachopoulous C. McDonald’s Blood Flow in Arteries, Sixth Edition: Theoretical, Experimental and Clinical Principles. Hodder Education Group 2011.
- Murakami T, Shiraishi M, Nawa T, et al. Loss of pulse pressure amplification between the ascending and descending aorta in patients after an aortic arch repair. J Hypertens. 2017; 35(3): 533–537.
- Delong C, Sharma S. Physiology, Peripheral Vascular Resistance. StatPearls [Internet], Treasure Island (FL) 2024.
- Masri S, El Rassi I, Arabi M, et al. Percutaneous closure of patent ductus arteriosus in children using amplatzer duct occluder II: relationship between PDA type and risk of device protrusion into the descending aorta. Catheter Cardiovasc Interv. 2015; 86(2): E66–E72.
- Welte M, Saugel B, Reuter DA. [Perioperative blood pressure management : What is the optimal pressure?]. Anaesthesist. 2020; 69(9): 611–622.
- de Graaff JC. Intraoperative blood pressure levels in young and anaesthetised children: are we getting any closer to the truth? Curr Opin Anaesthesiol. 2018; 31(3): 313–319.
- Sottas CE, Cumin D, Anderson BJ. Blood pressure and heart rates in neonates and preschool children: an analysis from 10 years of electronic recording. Paediatr Anaesth. 2016; 26(11): 1064–1070.
- Bijker JB, van Klei WA, Kappen TH, et al. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology. 2007; 107(2): 213–220.
- Wu PW, Yeh SJ, Lee PC, et al. Hemodynamic and Echocardiographic Characteristics and the Presence of Pulmonary Hypertension in Patent Ductus Arteriosus Patients who Underwent Transcatheter Closure. Pediatr Cardiol. 2023; 44(6): 1262–1270.
- Chinawa JM, Chukwu BF, Chinawa AT, et al. The effects of ductal size on the severity of pulmonary hypertension in children with patent ductus arteriosus (PDA): a multi-center study. BMC Pulm Med. 2021; 21(1): 79.
- McNamara PJ, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed. 2007; 92(6): F424–F427.
